Themis Medicare Share Price Today (THEMISMED)
TODAY IN ONE LINE
THEMISMED fell 2.0% on light volume, lagging Nifty's -0.0% move.
With a market cap of ₹971.66 Cr., it trades at a P/E of 883.33. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Themis Medicare flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●High Promoter HoldingPromoters hold 67.1% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.25x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●Poor Capital ReturnsLow ROE of 0.3%
- ●Expensive ValuationTrading at a high P/E ratio of 950.0x
Latest Themis Medicare News
What changed recently?
Recent events, corporate actions, and announcements.
Themis Medicare Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Themis Medicare Limited, framed against the sector median so the premium or discount is obvious at a glance.
Themis Medicare Limited trades at a P/E of 883.33× and P/B of 2.45×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Themis Medicare Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Themis Medicare Limited — derived from the live tape, not yesterday's close.
Themis Medicare Limited last traded at ₹105.78 with an intraday range of ₹105.16–₹111.51 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹105.78| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 122.51 | +16.73 | +15.81% |
| R3 | 116.16 | +10.38 | +9.81% |
| R2 | 113.83 | +8.05 | +7.61% |
| R1 | 109.81 | +4.03 | +3.81% |
| PIVOT | 107.48 | 1.70 | 1.61% |
| CURRENT | 105.78 | — | — |
| S1 | 103.46 | -2.32 | -2.20% |
| S2 | 101.13 | -4.65 | -4.39% |
| S3 | 97.11 | -8.67 | -8.20% |
| S4 | 90.76 | -15.02 | -14.20% |
THEMISMED is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹106–₹111.51
Trading Below opening range, showing Bearishness
Themis Medicare Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Themis Medicare Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Themis Medicare Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹971.66 Cr. and reported EPS of ₹0.12.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 406 | 342 ▼ 15.6% |
| Sales Growth YoY %Derived | 6.22% | -15.60% |
| Other Income | 5 | 9 ▲ 100.5% |
| Total Income | 410 | 352 ▼ 14.3% |
| 132 | 129 ▼ 1.9% | |
| Gross ProfitDerived | 274 | 213 ▼ 22.2% |
| Gross Margin %Derived | 67.45% | 62.17% |
| 224 | 212 ▼ 5.4% | |
| EBITDA (Operating Profit)Derived | 49 | 0 ▼ 99.2% |
| OPM %Derived | 12.10% | 0.11% |
| 20 | 20 ▲ 0.9% | |
| Profit Before Tax (PBT) | 34 | -12 ▼ 135.9% |
| 10 | 1 ▼ 92.0% | |
| Effective Tax %Derived | 29.16% | -6.47% |
| Total Profit for Period | 30 | 1 ▼ 96.2% |
| Less: Non-controlling Interests | -0 | -0 ▲ 0.0% |
| Net Profit (Owner's PAT)Derived | 30 | 1 ▼ 96.2% |
| Net Profit Margin %Derived | 7.36% | 0.33% |
| PAT Growth YoY %Derived | -31.46% | -96.17% |
| Earnings Per Share (EPS ₹) | 3.24 | 0.12 ▼ 96.3% |
| Diluted Shares Outstanding (Cr) | 9 | 9 ▲ 0.1% |
| Share of Profit from Associates/JVs | 6 | 14 ▲ 137.1% |
| Other Comprehensive Income (Net of Tax) | -0 | -1 ▼ 131.9% |
| Total Expenses (incl. D&A & Interest) | 376 | 364 ▼ 3.4% |
| Material Cost % of RevenueDerived | 18.82% | 16.74% |
| Employee Cost % of RevenueDerived | 23.77% | 27.33% |
| Other Cost % of RevenueDerived | 31.59% | 34.73% |
| Interest Coverage (x)Derived | 3.90x | -0.93x |
| Period | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | 212 | 184 ▼ 13.2% | 202 ▲ 9.7% | 231 ▲ 14.4% | 395 ▲ 71.1% | 354 ▼ 10.2% | 382 ▲ 7.7% | 406 ▲ 6.2% | 342 ▼ 15.6% | |
| Sales Growth YoY %Derived | — | -13.20% | 9.71% | 14.43% | 71.07% | -10.21% | 7.74% | 6.22% | -15.60% | |
| Other Income | 3 | 3 ▼ 11.4% | 3 ▲ 29.9% | 4 ▲ 4.5% | 7 ▲ 80.6% | 12 ▲ 75.9% | 5 ▼ 58.7% | 5 ▼ 1.8% | 9 ▲ 100.5% | |
| Total Income | 215 | 186 ▼ 13.2% | 205 ▲ 10.0% | 234 ▲ 14.3% | 401 ▲ 71.2% | 366 ▼ 8.8% | 387 ▲ 5.7% | 410 ▲ 6.1% | 352 ▼ 14.3% | |
72 | 68 ▼ 4.7% | 63 ▼ 7.5% | 79 ▲ 24.4% | 148 ▲ 88.5% | 118 ▼ 20.1% | 137 ▲ 15.5% | 132 ▼ 3.5% | 129 ▼ 1.9% | ||
| Gross ProfitDerived | 140 | 115 ▼ 17.6% | 138 ▲ 19.9% | 152 ▲ 9.9% | 246 ▲ 62.1% | 236 ▼ 4.3% | 245 ▲ 3.9% | 274 ▲ 11.6% | 213 ▼ 22.2% | |
| Gross Margin %Derived | 66.15% | 62.83% | 68.66% | 65.94% | 62.46% | 66.59% | 64.19% | 67.45% | 62.17% | |
115 | 113 ▼ 1.6% | 103 ▼ 9.2% | 103 ▼ 0.1% | 151 ▲ 47.0% | 169 ▲ 11.7% | 194 ▲ 14.9% | 224 ▲ 16.0% | 212 ▼ 5.4% | ||
| EBITDA (Operating Profit)Derived | 25 | 2 ▼ 90.9% | 36 ▲ 1464.5% | 49 ▲ 38.8% | 96 ▲ 93.2% | 67 ▼ 29.5% | 52 ▼ 23.6% | 49 ▼ 4.8% | 0 ▼ 99.2% | |
| OPM %Derived | 11.82% | 1.24% | 17.69% | 21.46% | 24.24% | 19.04% | 13.49% | 12.10% | 0.11% | |
19 | 20 ▲ 2.7% | 21 ▲ 6.8% | 21 ▲ 0.5% | 18 ▼ 14.1% | 20 ▲ 9.9% | 22 ▲ 7.8% | 20 ▼ 7.7% | 20 ▲ 0.9% | ||
| Profit Before Tax (PBT) | 9 | -15 ▼ 270.0% | 18 ▲ 220.9% | 32 ▲ 77.3% | 84 ▲ 163.4% | 59 ▼ 29.8% | 35 ▼ 41.2% | 34 ▼ 2.6% | -12 ▼ 135.9% | |
0 | -2 ▼ 1904.9% | 2 ▲ 213.9% | 6 ▲ 168.9% | 22 ▲ 297.7% | 16 ▼ 30.2% | 10 ▼ 36.5% | 10 ▼ 0.8% | 1 ▼ 92.0% | ||
| Effective Tax %Derived | 1.16% | 12.36% | 11.65% | 17.67% | 26.67% | 26.51% | 28.64% | 29.16% | -6.47% | |
| Total Profit for Period | 11 | -11 ▼ 195.8% | 25 ▲ 330.3% | 36 ▲ 44.1% | 73 ▲ 104.1% | 57 ▼ 21.9% | 44 ▼ 23.5% | 30 ▼ 31.5% | 1 ▼ 96.2% | |
| Less: Non-controlling Interests | -0 | -0 ▲ 71.1% | -0 ▲ 99.5% | -0 ▲ 0.0% | -0 ▲ 0.0% | -0 ▼ 100.0% | -0 ▼ 50.0% | -0 ▲ 33.3% | -0 ▲ 0.0% | |
| Net Profit (Owner's PAT)Derived | 11 | -11 ▼ 195.1% | 25 ▲ 330.7% | 36 ▲ 44.1% | 73 ▲ 104.1% | 57 ▼ 21.9% | 44 ▼ 23.5% | 30 ▼ 31.5% | 1 ▼ 96.2% | |
| Net Profit Margin %Derived | 5.34% | -5.85% | 12.29% | 15.48% | 18.47% | 16.06% | 11.40% | 7.36% | 0.33% | |
| PAT Growth YoY %Derived | — | -195.08% | 330.71% | 44.07% | 104.13% | -21.93% | -23.51% | -31.46% | -96.17% | |
| Earnings Per Share (EPS ₹) | 1.23 | -1.17 ▼ 195.1% | 2.70 ▲ 330.8% | 3.89 ▲ 44.1% | 7.92 ▲ 103.6% | 6.18 ▼ 22.0% | 4.73 ▼ 23.5% | 3.24 ▼ 31.5% | 0.12 ▼ 96.3% | |
| Diluted Shares Outstanding (Cr) | 9 | 9 ▲ 0.0% | 9 ▲ 0.1% | 9 ▲ 0.0% | 9 ▲ 0.1% | 9 ▲ 0.0% | 9 ▲ 0.0% | 9 ▲ 0.0% | 9 ▲ 0.1% | |
| Share of Profit from Associates/JVs | 3 | 2 ▼ 12.5% | 9 ▲ 292.7% | 9 ▲ 6.4% | 11 ▲ 19.7% | 14 ▲ 20.1% | 19 ▲ 38.1% | 6 ▼ 68.5% | 14 ▲ 137.1% | |
| Other Comprehensive Income (Net of Tax) | -0 | -0 ▲ 62.1% | -0 ▼ 51.4% | -0 ▼ 471.0% | -0 ▲ 16.9% | -0 ▼ 27.6% | -1 ▼ 71.4% | -0 ▲ 59.9% | -1 ▼ 131.9% | |
| Total Expenses (incl. D&A & Interest) | 206 | 201 ▼ 2.3% | 187 ▼ 7.1% | 202 ▲ 8.2% | 317 ▲ 56.7% | 307 ▼ 3.2% | 352 ▲ 14.6% | 376 ▲ 7.0% | 364 ▼ 3.4% | |
| Material Cost % of RevenueDerived | 25.16% | 26.79% | 25.49% | 29.45% | 28.80% | 27.11% | 22.18% | 18.82% | 16.74% | |
| Employee Cost % of RevenueDerived | 21.09% | 24.87% | 21.96% | 17.34% | 13.17% | 18.67% | 21.59% | 23.77% | 27.33% | |
| Other Cost % of RevenueDerived | 33.24% | 36.72% | 29.01% | 27.14% | 25.05% | 28.89% | 29.11% | 31.59% | 34.73% | |
| Interest Coverage (x)Derived | 1.48x | -0.48x | 2.13x | 3.22x | 9.82x | 5.96x | 4.19x | 3.90x | -0.93x |
Themis Medicare segment analysis : revenue and profit mix.
Disclosed business segments at Themis Medicare with their share of revenue and profit, switchable between consolidated and standalone reporting.
Themis Medicare discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Themis Medicare Limited.
Our AI distills the core fundamental drivers supporting Themis Medicare Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Themis Medicare Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Strong promoter holding of 67.1% ensures long-term stability and governance commitment.
Low debt-to-equity ratio of 0.25x provides financial flexibility and balance sheet safety.
Quarterly sales grew 6.74% YoY, demonstrating consistent revenue momentum in latest quarter.
TTM revenue growth of 6.70% reflects positive market traction despite operational headwinds.
Diversified therapeutic portfolio spans anti-TB, cardiology, orthopedics, and nutraceuticals.
Key Risks.
Operating margin of -2.90% signals severe profitability and operational efficiency challenges.
Extreme P/E ratio of 978x indicates severe overvaluation and significant investor skepticism.
Negative operating cash flow per share of -0.3545 raises liquidity sustainability concerns.
ROE of 0.29% and ROCE of 2.74% far below industry benchmarks, poor capital efficiency.
Latest quarterly EPS flat YoY despite 192% profit growth, raising earnings quality concerns.
Flip Conditions.
Valuation risk. a P/E above 1148 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 25.61. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
Themis Medicare Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Themis Medicare Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Themis Medicare Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Themis Medicare Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Themis Medicare Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Themis Medicare Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Themis Medicare Limited stood at 55.6% of traded volume, against a 20-day average of 43.3%.
Themis Medicare announcements: results, concalls, ratings, M&A.
Filings Themis Medicare sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Themis Medicare files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 58 documents below.
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Themis Medicare Limited has informed the Exchange about Certificate under 74(5) of SEBI (Depositories and Participants) Regulations, 2018
Spurt in Volume
Significant increase in volume has been observed in Themis Medicare Limited. The Exchange, in order to ensure that investors have latest relevant…
Copy of Newspaper Publication
Themis Medicare Limited has informed the Exchange about Copy of Newspaper Publication
Investor Presentation
Themis Medicare Limited has informed the Exchange about Investor Presentation
Outcome of Board Meeting
Themis Medicare Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
Investor decks & rating reports.
Themis Medicare dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Themis Medicare has declared, sequenced by announce and record date.
Themis Medicare corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Themis Medicare Limited: business, sector, key facts.
What Themis Medicare Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Themis Medicare Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: THEMISMED, BSE: 530199.
Themis Medicare Limited is a pharmaceutical company with a significant presence in India and international markets. Its core business revolves around the manufacture and sale of pharmaceutical products, encompassing both Active Pharmaceutical Ingredients (APIs) and finished formulations. This broad portfolio allows them to cater to a wide range of therapeutic needs.
The company's product offerings span numerous therapeutic areas, reflecting a diverse and comprehensive approach to pharmaceutical development and distribution. Key therapeutic categories include anti-tuberculosis and anti-malarial medications, addressing significant global health challenges. They also produce formulations for cardiology, pain management, and anti-infectives, demonstrating a focus on common and critical health concerns.
Furthermore, Themis Medicare's product line extends to haematinics (agents that increase red blood cell production), health and nutrition supplements, anaesthetics, gynaecological medications, and orthopedic pharmaceuticals. This extensive range indicates a commitment to providing a wide array of solutions across diverse medical specialties. The inclusion of anti-inflammatory drugs further broadens their reach within the common therapeutic landscape.
Established in 1952 and headquartered in Mumbai, India, Themis Medicare Limited has a long history within the pharmaceutical industry. Initially known as Themis Chemicals, the company rebranded to its current name in 2001, reflecting its evolution and growth. Their long-standing presence in the market suggests a significant level of experience and established industry connections.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs and Pharmaceuticals (AKUMS) Share PricePeer
- Other overvalued NSE stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Stock Quality ScorecardScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Themis Medicare Limited (THEMISMED).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Themis Medicare Limited (THEMISMED)?
The current share price of Themis Medicare Limited (THEMISMED) is ₹105.78. Today, the stock has declined by ₹2.15 (1.99%), trading in a range of ₹105.16 to ₹111.51. The stock opened at ₹106.51 with a trading volume of 34,271 shares.
02Is Themis Medicare Limited stock a good investment for long-term?
Themis Medicare Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹971.66 crores, P/E ratio of 883.33, ROE of 0.29%, and ROCE of 2.74%. The dividend yield stands at 0.43%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Themis Medicare Limited stock?
The 52-week high price of Themis Medicare Limited (THEMISMED) is ₹148, while the 52-week low is ₹64.95. Currently trading at ₹105.78, the stock is 49.2% away from its 52-week low and 28.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Themis Medicare Limited stock at the current price?
Whether to buy Themis Medicare Limited stock at ₹105.78 depends on multiple factors. The stock is currently trading with a P/E ratio of 883.33 and P/B ratio of 2.45. Today's performance shows a loss of 1.99%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Themis Medicare Limited and when is the next dividend?
Themis Medicare Limited offers a dividend yield of 0.43%, which means for every ₹100 invested at the current price of ₹105.78, you can expect to receive approximately ₹0.43 annually as dividends. The face value of the stock is ₹1.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Themis Medicare Limited?
Themis Medicare Limited's key financial metrics include: P/E Ratio: 883.33, P/B Ratio: 2.45, ROE: 0.29%, ROCE: 2.74%, Dividend Yield: 0.43%, EPS: ₹0.12, Book Value: ₹43.06, and Debt-to-Equity: 25.11. The company's market cap stands at ₹971.66 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Themis Medicare Limited stock performing today in the market?
Themis Medicare Limited stock opened at ₹106.51 and is currently trading at ₹105.78, showing a decline of ₹2.15 (1.99%). The intraday high is ₹111.51 and low is ₹105.16. The trading volume stands at 34,271 shares, indicating moderate market participation today.
08What is the P/E ratio of Themis Medicare Limited and what does it indicate?
Themis Medicare Limited has a Price-to-Earnings (P/E) ratio of 883.33, which means investors are willing to pay ₹883.33 for every ₹1 of earnings. With an EPS of ₹0.12, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Themis Medicare Limited (THEMISMED) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.